Fluvoxamine for fatigue after covid-19
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests the antidepressant fluvoxamine to see if it can reduce long-term fatigue in adults who developed severe tiredness after a covid-19 infection. You may join if your fatigue started or got worse after covid and has lasted at least 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been severely tired for at least 3 months after a covid-19 infection
- You can speak Dutch or English well enough to complete questionnaires
- You can join a video call
- You are willing to share medical information with your doctor and pharmacy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called Sonlicromanol to see if it helps people with lingering symptoms after a mild case of COVID-19. It is for people who have post-exertional malaise (feeling very tired or worse after activity) and a moderate level of disability.
This trial tests different treatments for long COVID (PCC) symptoms like fatigue and brain fog that started after a COVID infection. It aims to find which treatments help people recover.
This trial studies whether a yoga program (compared with health education) can reduce persistent tiredness after COVID-19. It may help if your fatigue has lasted at least 12 weeks and you think it started with COVID.
This trial tests a non-invasive brain stimulation method called Transcranial Pulse Stimulation (TPS) to see if it can help people with lingering post-COVID symptoms like fatigue and brain fog. If you've had COVID-19 and still have symptoms for at least 12 months, this study might be an option for you.
This study tests whether a personalized exercise program can help reduce fatigue after a COVID-19 infection. You'll work with a coach over video calls to see if gentle activity can improve your energy levels.
This trial uses brain scans to understand why people with long COVID feel very tired or have trouble thinking clearly. It could help find new treatments for these symptoms.
Hear when a new POST-Covid 19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.